Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. A.L. Messchendorp

Publicaties

Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patients

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination

Kidney Transplant Recipients Develop Nasal Mucosal Antibodies to SARS-CoV-2 With ACE2-Inhibiting Activity Following mRNA Vaccination

Unveiling Donor-Derived BKPyV DNAemia Through Analysis of Contralateral Kidney Transplant Recipients

Replacing Mycophenolate Mofetil by Everolimus in Kidney Transplant Recipients to Increase Vaccine Immunogenicity: Results of a Randomized Controlled Trial

The phenotype and functionality of spike-specific CD4+ T cells after COVID-19 vaccination associates with time after transplantation in transplant recipients

Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant Recipients

Patient engagement as a collaborative process in a large Dutch COVID-19 vaccination study (RECOVAC) - insight into the contribution of patient engagement and learnings for the future

Post COVID-19 condition imposes significant burden in patients with advanced chronic kidney disease: a nested case-control study

Repeated COVID-19 Vaccination Drives Memory T- and B-cell Responses in Kidney Transplant Recipients: Results From a Multicenter Randomized Controlled Trial

Pers/media

Immunosuppressive Drugs for Organ Transplant Increase COVID-19 Hospitalization Risk

Immunosuppressive Drugs for Organ Transplant Up COVID-19 Hospitalization Risk

The REnal Patients COVID-19 VACcination Immune Response (RECOVAC IR) Study (RECOVAC-IR)